Cat. No.: X24-08-YM250
Microtubule/Tubulin inhibitor, Mal-PEG2-VCP-eribulin, Purity ≥98%
Synonym: 2130869-18-8; Mal-PEG2-VC-PAB-eribulin; [4-[[(2S)-5-(Carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methyl N-[(2S)-2-hydroxy-3-[(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-21-methoxy-14-methyl-8,15-dimethylidene-24-oxo-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-20-yl]propyl]carbamate
- CAS Number: 2130869-18-8
- Compound CID: 138911392
Product Size
1 mg; 2 mg; 5 mg; 10 mg
Properties
Description
Mal-PEG2-VCP-eribulin is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Formula
C70H99N7O21
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Mal-PEG2-VCP-eribulin is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of cancer.
Storage
Store at -20ºC, and keep desiccated.
Related Products
- Microtubule/Tubulin inhibitor, Monomethyl auristatin E, Purity ≥98%
- Microtubule/Tubulin inhibitor, ABT-751, Purity ≥98%
- Microtubule/Tubulin inhibitor, Albendazole, Purity ≥98%
- Microtubule/Tubulin inhibitor, Chloroxine, Purity ≥98%
- Microtubule/Tubulin inhibitor, CYT997, Purity ≥98%
- Microtubule/Tubulin inhibitor, Epothilone A, Purity ≥98%
